Rosthea F10

Rosthea-F10 from Voithea Healthcare is an advanced lipid-lowering combination tablet containing Rosuvastatin 10mg and Fenofibrate 160mg. This dual-action therapy targets multiple lipid parameters by reducing LDL cholesterol, triglycerides, and total cholesterol while increasing HDL cholesterol. Rosuvastatin, a statin, inhibits cholesterol synthesis in the liver, while Fenofibrate works by enhancing lipid metabolism—making Rosthea-F10 ideal for patients with mixed dyslipidemia or combined hyperlipidemia.

Specially formulated for individuals at high risk of cardiovascular disease, Rosthea-F10 helps prevent complications such as heart attacks, strokes, and atherosclerosis. With Voithea Healthcare’s trusted quality and efficacy, Rosthea-F10 offers comprehensive lipid control for better heart health and long-term cardiovascular protection.